Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-1,39
KB1182-1,09
PKN108,62108,640,63
Msft-0,13
Nokia5,936,020,64
IBM1,10
Mercedes-Benz Group AG57,6757,690,05
PFE0,40
16.02.2026 18:00:58
Indexy online
AD Index online
select
AD Index online
 

  • 16.02.2026 17:35:32
STRATEC Biomed N (Xetra)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
19,36 -2,81 -0,56 194 547
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.02.2026
Popis společnosti

Business Summary: Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Financial Summary: BRIEF: For the three months ended 30 September 2025, Stratec SE revenues decreased 67% to EUR57M. Net income decreased 69% to EUR1.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other Operating Income decrease of 71% to EUR1.1M (income), Other interest expenses decrease from EUR89K (income) to EUR117K (expense).



  • Poslední aktualizace: 16.02.2026
Management společnosti
Data nejsou k dispozici